atuzaginstat
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Dec 11, 2017 (NCT03331900)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
NCCCC[C@H](NC(=O)C1CCCC1)C(=O)COc1c(F)ccc(F)c1F- Mol. weight
- 386.41 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095230 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04920903 | Phase 1 | Aug 26, 2021 | Cortexyme Inc. |
| NCT03823404 | Phase 2/Phase 3 (Phase 3) | Mar 28, 2019 | Cortexyme Inc. |
| NCT03418688 | Phase 1 | Mar 6, 2018 | Cortexyme Inc. |
| NCT03331900 | Phase 1 | Dec 11, 2017 | Cortexyme Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cortexyme Inc. | For profit | 4 | 4 | 2 | 2017 |
1 organizations
Page 1 / 1